For serum KL-6 in just the SSc-ILD patients, those with KL-6 ≥ 1000 U/mL had worse survival than those with KL-6 < 1000 U/mL (p = 0.049) (Fig 3C). Here, MUC1 is linked to systemic sclerosis.